Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader…
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
April 16, 2025 08:00 ET | Source: Nautilus Biotechnology Inc. SEATTLE, April…
Anbio Biotechnology AnnouncesClosing of Initial Public Offering
Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology…
Anbio Biotechnology Announces Pricing of Initial Public Offering
Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology…
Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan Drug and Rare Pediatric Disease Designations from the FDA
SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneer of…